Page 2 - Orexia Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2021 News provided by Share this article Share this article TOKYO and CAMBRIDGE, England, May 12, 2021 /PRNewswire/  Sosei Group Corporation ( the Company ) (TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2021. The full report can be accessed by clicking here.  Shinichi Tamura, Chairman, President and CEO of Sosei Heptares, commented:  We continue to make good progress expanding our drug discovery business and remain well positioned to capitalize on a range of growth opportunities. We have initiated several exciting new technology collaborations designed to enhance our world-leading discovery platform and extend the reach of its application, including beyond GPCRs for the first time. We have made good progress with our partnered programs, which have delivered multiple milestones and generated important revenue

United kingdomAbbvie allerganMetrion biosciencesSosei heptaresHironoshin nomuraShinichi tamuraGenentech rocheShinichiro nishishitaCitigate dewe rogersonSosei heptareSosei group corporationInternational mediaFormosa pharmaceuticalsSosei groupSosei group corporation the companyNational insurance